Orchid Pharma Limited — Important, 10-03-2025: Updates

Orchid Pharma Limited is moving forward with the amalgamation of Dhanuka Laboratories Limited, following the submission of a Joint Company Application to the Hon’ble National Company Tribunal (NCLT). A hearing on this matter took place, resulting in the NCLT reserving its order for a future announcement. The interim order reflecting this reservation has been made available on the NCLT's website. Once the final order is pronounced, Orchid Pharma will promptly inform the stock exchanges. This development marks a significant step in the company’s strategic restructuring, which could enhance its operational capabilities and market presence. Investors should watch closely for the NCLT's upcoming decision, as it could impact the future trajectory of Orchid Pharma.